The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number:3235-0006
Expires:Oct 31, 2018
Estimated average burden
hours per response:23.8

COLUMN 1COLUMN 2COLUMN 3COLUMN 4COLUMN 5COLUMN 6COLUMN 7COLUMN 8
VALUESHRS ORSH/PUT/INVESTMENTOTHERVOTING AUTHORITY
NAME OF ISSUERTITLE OF CLASSCUSIP(x$1000)PRN AMTPRNCALLDISCRETIONMANAGERSOLESHAREDNONE
AT&T INCCOM00206R1025,221147,650SH OTR10147,6500
BED BATH & BEYOND INCCOM07589610011,324197,344SH OTR10197,3440
BIOGEN IDEC INC COMCOM09062X1033,0079,538SH OTR109,5380
BIOMARIN PHARMACEUTICA COMCOM09061G1013,73360,000SH OTR1060,0000
HEWLETT-PACKARD COMPANYCOM4282361033,368100,000SH OTR10100,0000
KINDER MORGAN ENERGY PARTNERUT LTD PARTNER4945501068,395102,115SH OTR10102,1150
KINDRED HEALTHCARE INCCOM4945801035,783250,338SH OTR10250,3380
TEVA PHARMACEUTICALS INDS LTDADR8816242094,36183,198SH OTR1083,1980
TRIPLE - S MGMT CORPCOM8967491088,944498,851SH OTR10498,8510